confirmed the oncogenic role of METTL3 in CRC by inducing lncRNA LBX2-AS1 m6A hypermethylation to enhance its mRNA stability, resulting in significant increases in LBX2-AS1 mRNA in CRC cells. This evidence concerns the gene LBX2-AS1 and colorectal carcinoma.